Introduction
============

Symptoms of gastroesophageal reflux disease (GERD) are common, affecting 10%--30% of the population in Western countries ([@b14-ijgm-1-59]). Recently, the prevalence of GERD is also increasing in a Japanese population with a high prevalence of atrophic gastritis ([@b11-ijgm-1-59]). Respiratory diseases are also common causes for consultation in primary care, but the association between the two diseases remains unclear. Many previous studies of the association between the two had selection bias since data were obtained in a retrospective manner. Studies addressing the correlation between respiratory disorders and GERD symptoms in an unselected group of persons are sparse. The incidence of chronic bronchitis, asthma, and chronic pulmonary disease is 1.5 times more in patients with reflux esophagitis ([@b8-ijgm-1-59]). Other studies demonstrated a high prevalence of GERD in asthmatic patients ([@b28-ijgm-1-59]; [@b31-ijgm-1-59]). Thus, although there have been many studies that showed a close association between GERD symptoms and chronic cough, it has been unknown whether acute cough is also associated with GERD. The aim of this study was to evaluate the relationship between GERD and respiratory symptoms in general practice.

Patients and methods
====================

Between September 2005 and March 2006, 1725 consecutive patients (788 men and 937 women with a mean age of 42 years) who first attended the Outpatient Department of General Medicine and Emergency Care of Toho University Omori Hospital were enrolled in the present study. Informed consent was obtained from all of the patients. None of the patients had a history of use of proton pump inhibitor (PPI), H2-receptor antagonist, antibiotics, steroids, or nonsteroidal antiinflammatory drugs for a period of at least two month before the investigation. Patients who had a previous history of partial gastrectomy were also excluded from the study. The study was carried out in accordance with the Declaration of Helsinki, and approved by the ethical committee at Toho University.

All of the patients who first attended our hospital were asked to respond the F-scale questionnaire regardless of their chief complaints. The questionnaire is a self-report instrument containing 12 questions written in a simple and easy-to-understand language. As reported previously by [@b20-ijgm-1-59], the following definitions were used to identify symptoms in the F-scale: 1) "Do you get heartburn?"; 2) "Does your stomach feel bloated?"; 3) "Does your stomach ever feel heavy after meals?"; 4) "Do you sometimes subconsciously rub your chest with your hand?"; 5) "Do you ever feel sick after meals?"; 6) "Do you get heartburn after meals?"; 7) "Do you have an unusual sensation in your throat?"; 8) "Do you feel full while eating meals?"; 9) "Do some things get stuck when you swallow?"; 10) "Do you get bitter liquid coming up into your throat?"; 11) " Do you burp a lot?"; and 12) "Do you get heartburn if you bend over?" Symptoms frequency was measured on the following scale: never = 0; occasionally = 1; sometimes = 2; often = 3; and always = 4. If the patient has a score of more than 7 point, GERD is considered as positive.

When a patient complains of cough that has been present for less than 3 weeks, it is considered to be an acute cough according to the ACCP evidence-based clinical practice guidelines ([@b4-ijgm-1-59]). When the cough lasts for more than 3 weeks, it is diagnosed as having nonacute cough in the present study.

All values are expressed as means ± SD. Comparisons of groups were made using Student's *t* test or chi-square tests as appropriate. A p value of \<0.05 was accepted as indicating statistical significance.

Results
=======

Over all, 656 (38%) patients were diagnosed as GERD and 226 (13%) had respiratory symptoms including cough, sputum, and/or dyspnea. GERD symptoms were found in 104 of 226 patients with respiratory symptoms and in 552 of 1499 patients without respiratory symptoms. Patients with respiratory symptoms had GERD symptoms more frequently than patients without respiratory symptoms with a statistical significance (p \< 0.01, [Table 1](#t1-ijgm-1-59){ref-type="table"}). F-scale score is significantly higher in patients with respiratory symptoms (7.3 ± 6.2) than in those without respiratory symptoms (4.4 ± 5.8) (p \< 0.01). There were no significant differences in age, male to female ratio, or the prpprtion of hypertension treated and current smokers between patients with and without respiratory symptoms ([Table 1](#t1-ijgm-1-59){ref-type="table"}).

Among 226 patients with respiratory symptoms, 115 were diagnosed as acute cough and had a F-scale score of 6.8 ± 6.3. The remaining 111 patients were considered as having nonacute cough and had a F-scale score of 7.7 ± 6.1. There was no significant difference in F-scale score between the two groups. 43 (37%) of 115 patients with acute cough and 48 (43%) of 111 with nonacute cough had GERD symptoms ([Table 2](#t2-ijgm-1-59){ref-type="table"}). The difference in prevalence of GERD between acute and nonacute cough groups did not reach statistical significance.

GERD prevalence was analyzed after excluding pharyngeal symptoms because F-scale includes a question about an unusual sensation in the throat (question 7). Comparison of GERD prevalence between patients with and without pharyngeal symptoms was shown in [Table 3](#t3-ijgm-1-59){ref-type="table"}. In patients with nonacute cough, those were found in 15 (60%) of 25 patients with pharyngeal symptoms and in 32 (38%) of 85 without them. For acute cough, 22 (42%) of 53 patients with pharyngeal symptoms, and 18 (31%) of 58 patients without pharyngeal symptoms were diagnosed as GERD. The differences in GERD prevalence between patients with and without pharyngeal symptoms did not reach a statistical significance in acute and nonacute cough groups.

Discussion
==========

GERD refers to the abnormal exposure of the esophageal mucosa to gastric contents. Several population based-surveys have reported typical GERD symptoms, including heartburn and acid regurgitation, at least yearly ranging from 26% to 60% ([@b27-ijgm-1-59]; [@b29-ijgm-1-59]; [@b17-ijgm-1-59]; [@b7-ijgm-1-59]). These results are concordant with our findings although GERD symptoms in the general population are less common in the East compared to the West ([@b13-ijgm-1-59]; [@b5-ijgm-1-59]). Since *Helicobacter pylori* infection may result in hypochlorhydria as seen in individuals with atrophic gastritis, *H. pylori*-infected patients seem to be at less risk of developing GERD ([@b22-ijgm-1-59]), as is generally observed in Japan with high prevalence of *H. pylori* infection. Recently, several reports showed an increasing trend of GERD in Asian countries in recent years ([@b13-ijgm-1-59]; [@b5-ijgm-1-59]; [@b21-ijgm-1-59]). Although it has been thought that a low acid secretion would be associated with a lower prevalence of GERD in the Far East, [@b18-ijgm-1-59] demonstrated that gastric acid secretion in Japan is rising in both *H. pylori*-positive and -- negative individuals. Actually, decreasing prevalence of *H. pylori* was observed in many countries ([@b3-ijgm-1-59]; [@b19-ijgm-1-59]; [@b26-ijgm-1-59]) as well as in Japan ([@b1-ijgm-1-59]).

On the other hand, there have been many studies that showed a close association between GERD symptoms and chronic cough ([@b28-ijgm-1-59]; [@b8-ijgm-1-59]; [@b31-ijgm-1-59]). Several possible mechanisms underlying a relation between GERD and respiratory symptoms have been proposed.

Two mechanisms have been postulated by which GERD may induce cough: firstly, microaspiration of gastric refluxate into the lung causing an exudative mucosal reaction; and secondly, a vagally mediated distal esophageal-tracheobronchial reflex leading to bronchospasm ([@b16-ijgm-1-59]). The foregut and the respiratory tract have common embryological origins and share a number of reflexes. The existence of a vagally mediated esophageal-tracheobronchial reflex could explain asthma worsening after a large meal ([@b23-ijgm-1-59]). Microaspiration has also been proposed as a cause of GERD induced bronchospasm. In guinea pig model, acid perfusion of the esophagus caused neurally mediated airway inflammation ([@b25-ijgm-1-59]). The intimate mechanisms of acid-induced airway obstruction are dependent on activation of capsaicin-sensitive sensory nerves, with the subsequent release of tachykinins, that modulate diverse aspects of airway dysfunction ([@b25-ijgm-1-59]). [@b32-ijgm-1-59] demonstrated direct evidence that ingestion of 200 mL of 0.1 N Hcl increased bronchial activity. [@b9-ijgm-1-59] reported increased minute ventilation due to sensations of discomfort during acid perfusion of the esophagus in patients with normal lung function. Thus, heightened bronchial reactivity, microaspiration, and a vagally mediated reflex mechanism are possible pathways.

The increased respiratory effort and cough augment abdominal pressure facilitating the retrograde movement of gastric contents ([@b10-ijgm-1-59]). Changes in lung volume may alter the relationship between the diaphragm and lower esophageal sphincter (LES) disrupting the physiological activity ([@b30-ijgm-1-59]). The effect of asthma medications as well as the negative intrathoracic pressure produces during the asthma attacks may overcome the protective effect of the LES, resulting in increased GERD ([@b31-ijgm-1-59]). Theophylline, a bronchodilator, has been shown to stimulate gastric acid secretion and lower the LES pressure ([@b12-ijgm-1-59]). Exposure to small amounts of acid has been proposed to result in impaired laryngopharyngeal sensitivity and thereby potentially increasing the risk of aspiration ([@b12-ijgm-1-59]). Using prolonged esophageal pH monitoring, chronic persistent cough without obvious pulmonary etiology was likely to be associated with episodes of otherwise asymptomatic gastroesophageal reflux ([@b24-ijgm-1-59]). Likewise, cough from any cause can precipitate gastroesophageal reflux ([@b15-ijgm-1-59]). From these viewpoints, the present study on relationship between GERD symptoms and acute cough was proposed.

Similarly to the results of previous studies ([@b28-ijgm-1-59]; [@b8-ijgm-1-59]; [@b31-ijgm-1-59]), patients with respiratory symptoms had GERD symptoms more frequently than patients without respiratory symptoms with a statistical significance in the present study. Although the GERD prevalence is higher in patients with nonacute cough than in those with acute cough, there was no significant difference. This suggests that even acute cough can cause an increase in intra-abdominal pressure which in turn may promote movement of gastric contents into the esophagus. It seems unlikely that GERD might cause acute cough because GERD is a chronic disease. Cough induced by GERD should be prolonged. [@b2-ijgm-1-59] investigated the temporal association between coughing or wheezing and reflux episodes in asthmatics and concluded that even though occasional coughing can lead to reflux, the opposite is far more common. Some patients sometimes complain of a persistent cough following symptoms of an upper respiratory tract infection in clinical practice. When cough has been present for at least 3 weeks, but not more than 8 weeks, a diagnosis of postinfectious cough should be considered ([@b4-ijgm-1-59]). The frequency of postinfectious cough increases to 25% to 50% ([@b6-ijgm-1-59]) and gastroesophageal reflux is considered to be one of its mechanisms, suggesting that medical treatment of acid reflux in acute phase of cough may reduce postinfectious cough although the pathogenesis is often multifactorial.

An epidemiological study on GERD could be considered accurate only when the whole study population undergoes invasive procedure. However, this would dramatically reduce the number of participants and prejudice the response rate of the study. F-scale, therefore, seems to be the most appropriate test for general practice patients in the management of GERD because it has made no use of endoscopy. F-scale covers various symptoms related to functional dyspepsia, as well as GERD. Among 12 questions in F-scale, the question 7 is closely related to sore throat, which is one of the most common symptoms observed in patients with an upper respiratory tract infection. It is likely that GERD prevalence in patients with acute cough is influenced by the presence of sore throat. We therefore analyzed the GERD prevalence after excluding the question 7, and there were no differences in GERD prevalence between patients with and without pharyngeal symptoms in acute and nonacute cough groups. This indicates that sore throat does not affect the results of this study.

In conclusion, patients with respiratory symptoms are at a significantly increased risk of developing GERD. There was no difference in GERD prevalence between patients with acute and nonacute cough, suggesting that development of GERD is associated with the presence of respiratory diseases regardless of the period of respiratory symptoms. It is more important that the association between GERD and acute cough be more widely recognized in the primary care physicians.
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###### 

Comparison of GERD prevalence and F-scale score between patients with and without respiratory symptoms

                    **Respiratory symptoms**   **p-value**   
  ----------------- -------------------------- ------------- -----------
                    (+)                        (−)           
  No. of patient    226                        1499          
  Age (years old)   41.9 ± 9.1                 43.1 ± 8.5    N.S.
  Male:Female       96:132                     692:805       N.S.
  Current smoker    79 (35%)                   485 (32%)     N.S.
  Hypertension      17 (8%)                    111 (7%)      N.S.
  F-scale score     7.3 ± 6.2                  4.4 ± 5.8     p \< 0.01
  No. of GERD       104 (46%)                  552 (37%)     p \< 0.01

**Abbreviation:** GERD, gastroesophageal reflux disease.

###### 

Comparison of GERD prevalence and F-scale score between patients with and acute and nonacute cough

                   **Acute cough**   **Nonacute cough**   **p-value**
  ---------------- ----------------- -------------------- -------------
  No. of patient   115               111                  
  F-scale score    6.8 +/− 6.3       7.7 +/− 6.1          N.S.
  No. of GERD      43 (37%)          48 (43%)             N.S.

**Abbreviation:** GERD, gastroesophageal reflux disease.

###### 

The GERD prevalence in patients with and without pharyngeal symptoms in acute and nonacute cough groups

                       **Nonacute cough**   **Acute cough**              
  -------------------- -------------------- ----------------- ---------- ----------
  Pharyngeal symptom   (+)                  (−)               (+)        (−)
  No. of patient       25                   85                53         58
  No. of GERD          15 (60%)             32 (38%)          22 (42%)   18 (31%)

**Abbreviation:** GERD, gastroesophageal reflux disease.
